No Detail Found!

Comparative in-vitro activity of the two carbapenems: meropenem and imipenem against clinical isolates

Author(s)
Abid Mahmood Department of Pathology, PNS Shifa, Karachi, Pakistan
Abstract
To compare the in-vitro activity of the two carbapenems i.e., imipenem and meropenem against the local clinical isolates at a tertiary care hospital. Design: It was a prospective in-vitro study. Place and Duration of Study: The study was conducted at the Department of Pathology, PNS Shifa, Karachi during 1996 and 1999. Materials and Methods: The bacterial pathogens for study were isolated from various clinical specimens. A total of 340 isolates including Staphylococcus aureus (n=65), Escherichia coli (n=72), Pseudomonas aeruginosa (n=69), Klebsiella pneumoniae (n=46), Enterobacter cloacae (n=11), Salmonella spp (n=51), Streptococcus spp (n=14) and miscellaneous gram negative rods (n=12) were studied. Antibiotic sensitivity pattern was studied by Modified Kirby Baur disk diffusion method using 10-microgram disks each of imipenem and meropenem. Comparison of activity was done by measuring the diameter of inhibition zone around the disk. Results: Meropenem showed slightly less activity than imipenem against most of the staphylococci but it was more active against most of the enterobacteriaceae and Pseudomonas aeruginosa. Only one Escherichia coli isolate was found resistant to meropenem while Pseudomonas aeruginosa (n=5) were found resistant to imipenem. Conclusion: Imipenem is more active against gram-positive cocci while meropenem has better activity against gram-negative rods. Resistance to both the drugs is quite low. Further in-vitro and in-vivo trials are required to evaluate these drugs against the local isolates/infection.
Publication Details
Page(s) 142-145
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 3, Year: 2001

Request the full text from PASTIC

Keywords
Microbial, Microbial sensitivity tests Antibiotics. Carbapenems. Imipenem. Meropenem. Drug resistance
References
.1993 .Emergingantim­i crobiarlesistancaendtheimmunocompromisehdost. din InfDis, 17(Suppl2) : S527-36.
.1992 .. Drugs, 44(3) : 408-44.
.1994 .MartineMzL eta/. Rolesof beta-lactamasaensd porins conducteidn 82 EuropeanlaboratorIine:sP.rogramme in activitiesof carbapenemsand cephalosporins and Abstractosf the6th InternationCaolngressfor againstKlebsiellapneumoniae AntimicrobAgents Chemother 1999; InfectiousDiseases. , 43(7) : 1969-73.
0

Citations

0

Downloads

76

Views